We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Adenosine Therapeutics has signed a worldwide collaboration and option agreement
with Ortho-McNeil Pharmaceutical to further develop A2B adenosine receptor antagonist
compounds for the potential treatment of Type II diabetes, asthma and other
disorders.
Shire Pharmaceuticals Group, based in Britain, said it licensed its HIV compound
SPD754 to Avexa Ltd., an Australian specialty anti-infectives company.
Biobase, the German specialist in commercial biological databases, announced
today the successful acquisition of Proteome Inc., a wholly-owned subsidiary
of Incyte Corporation.
SA's medicine manufacturers have indicated that they would continue to sell
medicines at the reduced prices stipulated by the disputed medicine-pricing
regulations, until the Constitutional Court has given direction on the matter.
KV Pharmaceutical has additional borrowing capacity with its lenders after amending
its loan agreements late last month, it said in a regulatory filing.
Southern Research Institute today formally announced that it has launched a
new for-profit company, Brookwood Pharmaceuticals, Inc., spinning out the Institute's
30-year old in-house drug delivery group which focuses on the development of
time-release formulations for pharmaceuticals delivery.
Amid a national debate over how to reform scientific
research and boost innovation, a leading voice for French biotechnology has
been meeting with government ministers to help close France's biotech gap with
the U.S. and Britain.